---
figid: PMC4959626__10.1177_1759720X16646703-fig1
figtitle: Uric acid pathway and action site of urate-lowering therapies
organisms:
- NA
pmcid: PMC4959626
filename: 10.1177_1759720X16646703-fig1.jpg
figlink: /pmc/articles/PMC4959626/figure/fig1-1759720X16646703/
number: F1
caption: Uric acid pathway and action site of urate-lowering therapies. *Drugs in
  italics are agents still under development or still not approved. **Dashed arrow
  representing lack of metabolic step in humans, due to evolutionary loss of uricase
  enzyme.PNP, purine nucleoside phosphorylase; XO, xanthine oxidase.
papertitle: 'Treatment of hyperuricemia in gout: current therapeutic options, latest
  developments and clinical implications.'
reftext: Sebastian E. Sattui, et al. Ther Adv Musculoskelet Dis. 2016 Aug;8(4):145-159.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9149225
figid_alias: PMC4959626__F1
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC4959626__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4959626__10.1177_1759720X16646703-fig1.html
  '@type': Dataset
  description: Uric acid pathway and action site of urate-lowering therapies. *Drugs
    in italics are agents still under development or still not approved. **Dashed
    arrow representing lack of metabolic step in humans, due to evolutionary loss
    of uricase enzyme.PNP, purine nucleoside phosphorylase; XO, xanthine oxidase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCX 4208
  - Ulodesine
  - Arhalofenate
  - Tranilast
  - Allantoin
  - Allopurinol
  - Benzbromarone
  - Uric acid
  - Hypoxanthine
  - Xanthine
---
